R. Barsoum1, B. De’Ambrosis1,2,3,4
Scalp melanoma has been recognised as an uncommon but clinically signiﬁcant entity in the literature; this diag- nosis is associated with a poorer prognosis. Even after accounting for common prognostic factors (thick Breslow, positive sentinel lymph node, presence of ulceration, older age and male gender) they had signiﬁcantly worse 5-year melanoma speciﬁc survival and overall survival rates of
24% lower than other melanoma sites. We propose late diagnosis related to the difﬁculties of a scalp examination is a signiﬁcant factor contributing to the poorer prognosis. The literature does not clearly outline a protocol for scalp examination, but rather focuses on trichoscopy. We will present a comprehensive scalp examination protocol with a focus on melanoma and keratinocyte cancer, and a novel observer-based technique to facilitate re-identiﬁcation of scalp lesions with efﬁciency and precision as developed by a Dermatologist with over 30 years of experience.
1. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epi- demiology, and End Results (SEER) Program. Arch Dermatol.
2. Ozao-Choy J, Nelson DW, Hiles J, et al. The prognostic importance of scalp location in primary head and neck melanoma. J Surg Oncol. 2017;116(3):337–343. https://doi.org/10.1002/jso.24679
A non-interventional-prospective-12-month study to characterise REAL-life effectiveness and treatmentpatterns of secukinumab, and current standard-of-care of chronic plaque psoriasis in Asia-Pacific & MiddleEast